SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-069904
Filing Date
2023-06-09
Accepted
2023-06-09 16:10:22
Documents
1
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318251-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2318251-2_4seq1.xml 4 4229
  Complete submission text file 0001104659-23-069904.txt   5694
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Cloyd Mary Ann (Reporting) CIK: 0001666769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 231005349